DOI QR코드

DOI QR Code

Evaluation of Endometrial Precancerous Lesions in Postmenopausal Obese Women - A High Risk Group?

  • Acmaz, Gokhan (Department of Obstetrics and Gynecology, Kayseri Education and Research Hospital of Medicine) ;
  • Aksoy, Huseyin (Department of Obstetrics and Gynecology, Kayseri Military Hospital) ;
  • Albayrak, Evrim (Department of Health Sciences, Erciyes University School of Medicine) ;
  • Baser, Muruvet (Department of Health Sciences, Erciyes University School of Medicine) ;
  • Ozyurt, Sezin (Department of Obstetrics and Gynecology, Kayseri Education and Research Hospital of Medicine) ;
  • Aksoy, Ulku (Department of Obstetrics and Gynecology, Kayseri Education and Research Hospital of Medicine) ;
  • Unal, Dilek (Department of Radiation Oncology, Kayseri Education and Research Hospital of Medicine)
  • 발행 : 2014.01.15

초록

Aim: To evaluate precancerous lesions such as hyperplasia and endometrial polyps in obese postmenopausal women. Materials and Methods: Women who were referred with abnormal uterine bleeding in postmenopausal period or the presence of endometrial cells on cervical cytology in our department were investigated. Anthropometric measurements such as height, weight, body mass index, waist/hip ratio and endometrial thickness were compared between a precancerous lesion (hyperplasia and endometrial polyp) group and a pathologically normal group. Results: We detected statistically significant thickening of endometrium in patients with precancerous lesions. Moreover patients with precancerous lesions had higher body mass index than the pathologically normal group. Conclusions: We found elevated precancerous lesion rates in overweight and obese women in the postmenopausal period, of interest given that the prevalence of obesity is increasing in most parts of the world. Although screening for endometrial cancer is not recommended for the general population, in high-risk populations like obese postmenopausal women, it may be very important.

키워드

참고문헌

  1. Anthony P (2001). Cheung Ultrasound and Menstrual History in Predicting Endometrial Hyperplasia in Polycystic Ovary Syndrome Obstetrics and Gynecology. ACOG, 98, 325-31.
  2. Bennett GL, Andreotti RF, Lee SI, et al (2011). ACR appropriateness criteria on abnormal vaginal bleeding. J Am Coll Radiol, 8, 460-8. https://doi.org/10.1016/j.jacr.2011.03.011
  3. Dubinsky TJ, Parvey HR, Gormaz G, et al (1995). Transvaginal hysterosonography: comparison with biopsy in the evaluation of postmenopausal bleeding. J Ultrasound Med, 14, 887-93.
  4. Epplein M, Susan D Reed, Lynda F Voigt, et al (2008). Weiss Risk of Complex and Atypical Endometrial Hyperplasia in Relation to Anthropometric Measures and Reproductive History. Am J Epidemiol, 168, 563-70. https://doi.org/10.1093/aje/kwn168
  5. Gredmark T, Kvint S, Havel G, Mattsson LA (1999). Adipose tissue distribution in postmenopausal women with adenomatous hyperplasia of the endometrium. Gynecol Oncol, 72, 138-42. https://doi.org/10.1006/gyno.1998.5252
  6. Heller DS, Mosquera C, Goldsmith LT, Cracchiolo B (2011). Body mass index of patients with endometrial hyperplasia: comparison to patients with proliferative endometrium and abnormal bleeding. J Reprod Med, 56, 110-2.
  7. Kleebkaow P, Maneetab S, Somboonporn W, et al (2008). Preoperative and Postoperative Agreement of Histopathological Findings in Cases of Endometrial Hyperplasia. Asian Pac J Cancer Prev, 9, 89-91.
  8. Kruk J, Czerniak U (2013). Physical Activity and its Relation to Cancer Risk: Updating the Evidence. Asian Pac J Cancer Prev, 14, 3993-4003. https://doi.org/10.7314/APJCP.2013.14.7.3993
  9. Lacey JV Jr, Sherman ME, Rush BB, et al (2010). Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia. J Clin Oncol, 28, 788-92. https://doi.org/10.1200/JCO.2009.24.1315
  10. Lasmar RB, Barrozo PR, Parente RC, et al (2010). Hysteroscopic evaluation in patients with infertility. Rev Bras Ginecol Obstet, 32, 393-7. https://doi.org/10.1590/S0100-72032010000800006
  11. Lasmar BP, Lasmar RB (2013). Endometrial Polyp Size and Polyp Hyperplasia. Int J Gynaecol Obstet, 0020-7292, 00425-6. [Epub ahead of print]
  12. Lieng M, Istre O, Sandvik L, et al (2009). Prevalence, 1-year regression rate, and clinical significance of asymptomatic endometrial polyps: cross-sectional study. J Minim Invasive Gynecol, 16, 465-71. https://doi.org/10.1016/j.jmig.2009.04.005
  13. Milenkovic V, Sparic R, Atanackovic J, et al (2005). Methods of screening for endometrial cancer. Srp Arh Celok Lek, 133, 199-201.
  14. Ogden CL, Yanovski SZ, Carroll MD, et al (2007). The epidemiology of obesity. Gastroenterology, 132, 2087-102. https://doi.org/10.1053/j.gastro.2007.03.052
  15. Reeves GK, Pirie K, Beral V, et al (2007). Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ, 335, 1134-45. https://doi.org/10.1136/bmj.39367.495995.AE
  16. Reinhold C, Khalili I (2002). Postmenopausal bleeding: value of imaging. Radiol Clin North Am, 40, 527-62. https://doi.org/10.1016/S0033-8389(01)00008-2
  17. Ronghe R, Gaudoin M (2010). Women with recurrent postmenopausal bleeding should be re-investigated but are not more likely to have endometrial cancer. Menopause Int, 16, 9-11.
  18. Tingthanatikul Y, Choktanasiri W, Rochanawutanon M, et al (2006). Prevalence and clinical predictors of endometrial hyperplasia in anovulatory women presenting with amenorrhea. Gynecol Endocrinol, 22, 101-5. https://doi.org/10.1080/09513590600585997
  19. Turan T, Karadag B, Karabuk E et al (2012). Accuracy of frozen sections for intraoperative diagnosis of complex atypical endometrial hyperplasia. Asian Pac J Cancer Prev, 13, 1953-56 https://doi.org/10.7314/APJCP.2012.13.5.1953
  20. Van den Bosch T, Vandendael A, Van Schoubroeck D, et al (1996). Acta Obstet Gynecol Scand, 75, 181-2. https://doi.org/10.3109/00016349609033315
  21. Viola AS, Gouveia D, Andrade L, et al (2008). Prevalence of endometrial cancer and hyperplasia in non-symptomatic overweight and obese women, Aust N Z J Obstet Gynaecol, 48, 207-13. https://doi.org/10.1111/j.1479-828X.2008.00845.x
  22. World Health Organization. WHO Technical Report Series 854. Geneva: 1995. Physical Status: The use and interpretation of anthropometry. Report of a WHO Consultation. World Health Organ Tech Rep Ser, 854, 1-452

피인용 문헌

  1. Roles of Sonography and Hysteroscopy in the Detection of Premalignant and Malignant Polyps in Women Presenting with Postmenopausal Bleeding and Thickened Endometrium vol.15, pp.13, 2014, https://doi.org/10.7314/APJCP.2014.15.13.5355
  2. Risk Factors for Endometrial Hyperplasia Concomitant Endometrial Polyps in Pre- and Post-menopausal Women vol.15, pp.13, 2014, https://doi.org/10.7314/APJCP.2014.15.13.5423
  3. Utility of Frozen Section Pathology with Endometrial Pre-Malignant Lesions vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6053
  4. Risk Factors of Lymph Node Metastases with Endometrial Carcinoma vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6353
  5. Body Mass Index Effects on Risk of Ovarian Cancer: A Meta-Analysis vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7665
  6. Antiproliferative Effect of Metformin on the Endometrium - a Clinical Trial vol.15, pp.23, 2015, https://doi.org/10.7314/APJCP.2014.15.23.10067
  7. No Effect of Energy Intake Overall on Risk of Endometrial Cancers: a Meta-analysis vol.15, pp.23, 2015, https://doi.org/10.7314/APJCP.2014.15.23.10293
  8. The Polymorphism of Hypoxia-inducible Factor-1a Gene in Endometrial Cancer vol.15, pp.23, 2015, https://doi.org/10.7314/APJCP.2014.15.23.10393
  9. Relations of Serum Visfatin and Resistin Levels with Endometrial Cancer and Factors Associated with its Prognosis vol.16, pp.11, 2015, https://doi.org/10.7314/APJCP.2015.16.11.4503
  10. Thickness of preperitoneal fat as a predictor of malignancy in overweight and obese women with endometrial polyps vol.11, pp.3, 2016, https://doi.org/10.3892/ol.2016.4186